American Society of Addiction Medicine
American Society of Addiction Medicine
Lead: Medications for Opioid Use Disorder Playbook
Lead: Medications for Opioid Use Disorder Playbook
Lead: Medications for Opioid Use Disorder Playbook
Saturday 11th October 2025
Explore innovative approaches in addiction medicine, including a new MOUD Playbook and insights into environmental and genetic factors in AUD.
7 minutes
Informative
Educational
Inspiring
Supportive
Honest
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
183 (View all)
Do you want to link to this podcast?
Get the buttons here!Revolutionising Opioid Use Disorder Treatment: A New Playbook
Episode Overview
- AHRQ's MOUD Playbook provides practical guidance for healthcare providers.
- Environmental factors significantly impact alcohol use disorder across ancestries.
- Innovative low-threshold buprenorphine programs are emerging.
- Telehealth services are expanding addiction treatment in rural areas.
- Safer opioid supply program closures have significant impacts on users.
"The low-threshold approach ensures immediate access to MOUD, eliminating barriers for both patients and providers."
What remarkable journeys have people faced head-on against addiction? This episode of 'This Week in Addiction Medicine' dives into the world of medications for opioid use disorder (MOUD) with a spotlight on the AHRQ Integration Academy's new Playbook. Designed as a practical guide, the Playbook provides comprehensive resources for implementing MOUD in primary and ambulatory care settings. It offers tools, guidance, and examples to help healthcare providers offer low-threshold care and eliminate barriers for patients.
The episode also covers a fascinating study from The American Journal of Psychiatry, which explores how environmental, psychiatric, and genetic factors predict alcohol use disorder across different ancestries. The findings suggest that environmental factors play a significant role, but genetic factors also contribute. Listeners are introduced to innovative approaches like low-threshold buprenorphine programs in non-traditional settings and a telehealth addiction consultation service at a rural hospital.
These stories highlight the creative solutions being developed to meet the needs of individuals struggling with addiction. In another segment, the episode discusses the impact of safer opioid supply program closures in Ontario, capturing the voices of those affected by these changes. The episode wraps up with insights into ketamine-associated uropathy, shedding light on the potential risks and management strategies for those using ketamine therapeutically or recreationally. This episode is packed with valuable information and diverse perspectives on addiction medicine.
So, why not give it a listen and see what new ideas it sparks for you?